Market Access/ News/ News/ News/ R&D AstraZeneca, Avillion ‘first-in-class’ combination inhaler shines in Phase 3 trial Eloise McLennan albuterol, asthma, Astra Zeneca, Avillion, budesonide 0 Comment An albuterol/budesonide fixed-dose combination rescue medication has been shown to reduce severe exacerbations in patients with asthma for Share X AstraZeneca, Avillion ‘first-in-class’ combination inhaler shines in Phase 3 trial https://pharmaphorum.com/news/astrazeneca-avillion-first-in-class-combination-inhaler/